RECURRENT ADENOID CYSTIC CARCINOMA

Clinical trials for RECURRENT ADENOID CYSTIC CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT ADENOID CYSTIC CARCINOMA trials appear

Sign up with your email to follow new studies for RECURRENT ADENOID CYSTIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New pill targets rare Cancer's genetic driver

Disease control Recruiting now

This early-stage study is testing a new oral medication called REM-422 for people with advanced adenoid cystic carcinoma (ACC), a rare cancer. The main goals are to find a safe and effective dose and to see if the drug can shrink or control tumors. The study will enroll about 100…

Matched conditions: RECURRENT ADENOID CYSTIC CARCINOMA

Phase: PHASE1, PHASE2 • Sponsor: Remix Therapeutics • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

RECURRENT ADENOID CYSTIC CARCINOMA

Get alerted when new RECURRENT ADENOID CYSTIC CARCINOMA trials appear

New pill targets rare Cancer's genetic driver